Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit
Cannabis Stock Movers For September 25, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Corbus Pharmaceuticals(CRBP.US) 10% Shareholder Buys US$7 Million in Common Stock
$Corbus Pharmaceuticals(CRBP.US)$ 10% Shareholder Cormorant Asset Management, LP purchased 350K shares of common stock on Sep 20, 2024 at an average price of $20.011 for a total value of $7 million.
Cormorant Asset Management Buys $7m in Corbus Pharmaceuticals Stock
Mizuho Cuts Price Target on Corbus Pharmaceuticals Holdings to $42 From $74, Keeps Outperform Rating
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Sonova Holding AG (Six Swiss: CH:SOON) and Corbus Pharmaceuticals (CRBP)
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Announces Target Price $74
Mizuho Securities analyst Graig Suvannavejh maintains $Corbus Pharmaceuticals(CRBP.US)$ with a buy rating, and sets the target price at $74.According to TipRanks data, the analyst has a success rate
Mizuho Recommends Buying Corbus Following Its Drop Post-Novo's Obesity Data
H.C. Wainwright Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $80
H.C. Wainwright analyst Andres Y. Maldonado maintains $Corbus Pharmaceuticals(CRBP.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success
Buy Rating Affirmed for Corbus Pharmaceuticals on CRB-913's Potential and Holistic Pipeline Valuation
HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Maintains $80 Price Target
Express News | Corbus Pharmaceuticals Holdings Inc : B. Riley Cuts Target Price to $40 From $85
Oppenheimer Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $88
Oppenheimer analyst Jeff Jones maintains $Corbus Pharmaceuticals(CRBP.US)$ with a buy rating, and maintains the target price at $88.According to TipRanks data, the analyst has a success rate of 43.5%
U.S. stock market closing | The 'Triple Witching Day' saw violent fluctuations in the final trading hour, with the Dow hitting a new all-time high; Intel surged in the final hour, gold reached a new high, and the offshore RMB rose by 300 points.
The Dow Jones hit a new high, while small-cap index fell more than 1% after seven consecutive gains, and the S&P briefly stopped falling in late trading. The Dow rose 1.6% for the week, the Nasdaq rose 1.5%, and energy stocks drove the S&P up 1.4%, the fifth consecutive weekly gain in six weeks, with small-cap stocks rising more than 2% and China concept stocks rising nearly 4% for the week.
Cannabis Stock Movers For September 20, 2024
Sector Update: Health Care Stocks Fall Late Afternoon
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Corbus Pharmaceuticals Is Maintained at Buy by B. Riley Securities